The multi-billion-dollar cancer drug Avastin is no longer an approved treatment for breast cancer treatment , per a long-anticipated announcement made Friday by the U.S. Food and Drug Administration (FDA).

Avastin (bevacizumab, sold by Genentech/Roche) has been on the market since 2004 as a treatment for colon cancer. Following its lukewarm approval in 2008 for use against breast cancer, it came under increasing scrutiny for a lackluster track record with that disease.

[More]



Add to digg
Add to StumbleUpon
Add to Reddit
Add to Facebook
Add to del.icio.us
Email this Article





Source: Use of Avastin for Breast Cancer Nixed by FDA


David Cottle

UBB Owner & Administrator